Literature DB >> 19456884

Nasal sumatriptan as adjunctive therapy for idiopathic trigeminal neuralgia: report of three cases.

Keiko Shimohata1, Takayoshi Shimohata, Ryoichiro Motegi, Kou Miyashita.   

Abstract

We examine the effect of nasal sumatriptan as an adjunctive therapy in 3 patients with idiopathic trigeminal neuralgia refractory to carbamazepine (CBZ) and found that this therapy might be suitable for patients for whom the CBZ dose cannot be increased, who are under poor pain control, and who are not candidates for nerve blocks or surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19456884     DOI: 10.1111/j.1526-4610.2008.01254.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  1 in total

1.  Sumatriptan improves postoperative quality of recovery and reduces postcraniotomy headache after cranial nerve decompression.

Authors:  L Venkatraghavan; L Li; T Bailey; P H Manninen; M Tymianski
Journal:  Br J Anaesth       Date:  2016-07       Impact factor: 9.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.